Last reviewed · How we verify
NCT03577600
Compassionate Treatment in Children With Brain Tumors With the Cytotron®
NA trial testing QMRT with the Cytotron® in Pediatric Brain Tumor. Withdrawn.
31 December 2019
Quick facts
| Lead sponsor | Hospital Infantil de Mexico Federico Gomez |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Start date | 17 October 2018 |
| Primary completion | 31 December 2019 |
| Estimated completion | 31 July 2020 |
| Sites | 1 location across Mexico |
Drugs / interventions tested
- QMRT with the Cytotron®
Conditions studied
- Pediatric Brain Tumor — all drugs for Pediatric Brain Tumor →
Sponsor
Hospital Infantil de Mexico Federico Gomez
Who can join
Adults 3 to 16, any sex, with Pediatric Brain Tumor. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a prospective case-control study. This study is expected to last for approximately 12 months, comprised of 4-8 weeks of enrollment period, 28 days of treatment and 6 months of follow up. The enrollment will be completed prior to the beginning of initial treatment. The study will be closed when 10 subjects have completed the study. The recruitment will be carried out with a sample at convenience.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Compassionate use of Quantum Magnetic Resonance Therapy for treatment of children with Diffuse Brainstem Glioma in Mexico City: a single institutional experience.
Barragán-Pérez EJ, Alvarez-Amado DE, Dies-Suarez P, Tobón SH, et al · · 2022 · cited 1× · PMID 35266065 · DOI 10.1007/s11060-022-03972-2
Verify or expand the search:
- PubMed search for NCT03577600
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pediatric Brain Tumor
Currently open trials in the same condition.
- NCT06943742 — Non-Helium Magnetoencephalography in Pediatric Brain Tumors · recruiting
- NCT05887882 — Intra-Tumoral Injections of Natural Killer Cells for Recurrent Malignant Pediatric Brain Tumors · Phase 1 · recruiting
- NCT05740839 — High-Intensity Interval Exercise in Young Adult Survivors of Pediatric Brain Tumors: A Pilot Feasibility Study · NA · recruiting
- NCT05528939 — Feasibility/Acceptability of Attentional-Control Training in Survivors · NA · recruiting
- NCT05521984 — Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SG · Phase 1 · recruiting
Other Hospital Infantil de Mexico Federico Gomez trials
Trials by the same sponsor.
- NCT07376252 — Use of a Mobile Application by Parents to Prevent Obesity in Their Children Apply for Your Health · NA · enrolling by invitation
- NCT05431920 — Effects of Vitamin D Supplementation in Adolescents With Asthma, Obesity and Vitamin D Deficiency. · NA · active not recruiting
- NCT05276960 — Efficacy of Intensive Cholecalciferol Monitoring and Supplementation on Serum vitD Levels in Pediatric Patients With CF · Phase 4 · completed
- NCT03951558 — Comparison of the Impact of Diet vs Thiazide in BMD in Children With Idiopathic Hypercalciuria · NA · unknown
- NCT06174454 — Clinical Efficacy of Respiratory Pediatric Physiotherapy on a Child With Hospital Treated Pneumonia · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03577600 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital Infantil de Mexico Federico Gomez
- Last refreshed: 24 September 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03577600.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing